Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America.
Keck Advanced Microscopy Laboratory and Department of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.
PLoS Pathog. 2018 Jan 5;14(1):e1006830. doi: 10.1371/journal.ppat.1006830. eCollection 2018 Jan.
The lentiviral protein Viral Infectivity Factor (Vif) counteracts the antiviral effects of host APOBEC3 (A3) proteins and contributes to persistent HIV infection. Vif targets A3 restriction factors for ubiquitination and proteasomal degradation by recruiting them to a multi-protein ubiquitin E3 ligase complex. Here, we describe a degradation-independent mechanism of Vif-mediated antagonism that was revealed through detailed structure-function studies of antibody antigen-binding fragments (Fabs) to the Vif complex. Two Fabs were found to inhibit Vif-mediated A3 neutralization through distinct mechanisms: shielding A3 from ubiquitin transfer and blocking Vif E3 assembly. Combined biochemical, cell biological and structural studies reveal that disruption of Vif E3 assembly inhibited A3 ubiquitination but was not sufficient to restore its packaging into viral particles and antiviral activity. These observations establish that Vif can neutralize A3 family members in a degradation-independent manner. Additionally, this work highlights the potential of Fabs as functional probes, and illuminates how Vif uses a multi-pronged approach involving both degradation dependent and independent mechanisms to suppress A3 innate immunity.
慢病毒蛋白病毒感染性因子(Vif)拮抗宿主 APOBEC3(A3)蛋白的抗病毒作用,有助于持续的 HIV 感染。Vif 通过招募它们到一个多蛋白泛素 E3 连接酶复合物,来靶向 A3 限制因子进行泛素化和蛋白酶体降解。在这里,我们通过对 Vif 复合物的抗体抗原结合片段(Fab)的详细结构功能研究,描述了一种 Vif 介导的拮抗作用的非降解依赖机制。通过两种 Fab 发现,通过不同的机制抑制 Vif 介导的 A3 中和:遮蔽 A3 免受泛素转移和阻断 Vif E3 组装。综合生化、细胞生物学和结构研究表明,破坏 Vif E3 组装抑制了 A3 的泛素化,但不足以恢复其包装到病毒颗粒中和抗病毒活性。这些观察结果表明,Vif 可以以非降解依赖的方式中和 A3 家族成员。此外,这项工作强调了 Fab 作为功能探针的潜力,并阐明了 Vif 如何利用涉及降解依赖和非依赖机制的多管齐下的方法来抑制 A3 先天免疫。